Ligand Pharmaceuticals (LGNDZ) Interest Coverage Ratio (2016 - 2025)
Ligand Pharmaceuticals (LGNDZ) has disclosed Interest Coverage Ratio for 16 consecutive years, with 7.76 as the latest value for Q4 2025.
- Quarterly Interest Coverage Ratio rose 171.06% to 7.76 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8.7 through Dec 2025, up 216.67% year-over-year, with the annual reading at 8.7 for FY2025, 216.83% up from the prior year.
- Interest Coverage Ratio hit 7.76 in Q4 2025 for Ligand Pharmaceuticals, down from 60.36 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 3078.0 in Q3 2023 to a low of 83.75 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 156.79 across 5 years, with a median of 5.78 in 2024.
- Biggest five-year swings in Interest Coverage Ratio: plummeted 1092.11% in 2022 and later surged 8180.5% in 2023.
- Year by year, Interest Coverage Ratio stood at 8.44 in 2021, then tumbled by 1092.11% to 83.75 in 2022, then skyrocketed by 69.39% to 25.63 in 2023, then skyrocketed by 57.42% to 10.91 in 2024, then surged by 171.06% to 7.76 in 2025.
- Business Quant data shows Interest Coverage Ratio for LGNDZ at 7.76 in Q4 2025, 60.36 in Q3 2025, and 7.32 in Q2 2025.